CHCT Q3 2026 results show improving AFFO and strategic capital recycling progress
Nov 3, 2026, 4:42 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The combination of rising FFO/AFFO, modest revenue growth, and active capital recycling (dispositions and a $99M pipeline) suggests improved cash flow visibility. A stable dividend supports investor comfort, while the acquisition pipeline could drive future NAV and earnings upside if closings occur as expected. However, timing risk remains for the hospital-operator lease reconfiguration and the four proposed acquisitions.
AI summary
What happened, with direct paths to the underlying reporting
CHCT's Q3 2026 results reflect progress on the August 4 strategy, with 4% revenue growth and occupancy rising to 90.1%. FFO and AFFO per share advanced year over year, while dispositions totaling $32.3M bolster capital recycling. An LOI involving a hospital-operator tenant and a $99M acquisition pipeline could drive near-term cash flow and NAV, though timing remains uncertain.
CHCT Q3 2026 net income $3.1M; FFO $0.54, AFFO $0.58.
Occupancy rose to 90.1%; revenue up $1.2M (+4%).
G&A declined $0.7M; YoY FFO per share +0.04.
Dispositions totaling $32.3M since Q2; $99M acquisition pipeline.
Dividend declared $0.33; same as prior quarter.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
- CHCT reported quarterly FFO of $0.59 per share, missing estimates by -1.67%. - Revenues for CHCT were $29.33 million, falling short of estimates by 1.44%. - CHCT has underperfor…
